HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.
Ellenberger D, Otten RA, Li B, Aidoo M, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Wyatt L, Hudgens MG, Kraiselburd E, Moss B, Robinson H, Folks T, Butera S.
Ellenberger D, et al. Among authors: folks t.
Virology. 2006 Aug 15;352(1):216-25. doi: 10.1016/j.virol.2006.04.005. Epub 2006 May 24.
Virology. 2006.
PMID: 16725169
Free article.